Key Points
- CEO John C.M. Farquhar sold 27,230 Heartflow shares at $50 each for $1.36 million under a pre-arranged Rule 10b5-1 plan, reducing his stake by 7.02% to 360,814 shares. He has also made several other stock sales since June.
- Heartflow shares opened at $49.89, near their 52-week high of $51.19, with a market capitalization of approximately $4.34 billion. The stock has risen substantially above its 50-day and 200-day moving averages.
- The company beat quarterly EPS expectations, reporting a loss of $0.07 per share versus the expected $0.22 loss, while revenue increased 47.7% year over year to $64.08 million. Analysts maintain a “Moderate Buy” consensus with an average price target of $43.43.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John C.M. Farquhar sold 27,230 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer owned 360,814 shares of the company's stock, valued at approximately $18,040,700. This represents a 7.02% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John C.M. Farquhar also recently made the following trade(s):
- On Tuesday, August 18th, John C.M. Farquhar sold 32,676 shares of Heartflow stock. The shares were sold at an average price of $45.00, for a total transaction of $1,470,420.00.
- On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.
- On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total transaction of $638,730.22.
- On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total value of $626,095.50.
- On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00.
- On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total value of $643,017.00.
Heartflow Price Performance
Shares of NASDAQ HTFL opened at $49.89 on Wednesday. The stock has a fifty day moving average price of $31.36 and a 200 day moving average price of $28.63. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $51.19. The company has a market cap of $4.34 billion and a PE ratio of -27.26.
Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. Heartflow's quarterly revenue was up 47.7% on a year-over-year basis. Analysts anticipate that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Heartflow
Institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. purchased a new position in shares of Heartflow in the 3rd quarter valued at about $48,871,000. Legal & General Group Plc purchased a new stake in Heartflow during the third quarter worth about $59,000. Franklin Resources Inc. purchased a new stake in Heartflow during the third quarter worth about $10,829,000. UBS Group AG acquired a new position in Heartflow during the third quarter worth about $5,130,000. Finally, Sei Investments Co. purchased a new position in Heartflow in the third quarter valued at about $303,000.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the stock. Morgan Stanley boosted their price target on shares of Heartflow from $35.00 to $40.00 and gave the stock an "equal weight" rating in a research note on Friday, August 14th. Benchmark restated a "buy" rating on shares of Heartflow in a research report on Friday, August 14th. Wells Fargo & Company boosted their target price on Heartflow from $37.00 to $39.00 and gave the stock an "overweight" rating in a research report on Friday, August 14th. Stifel Nicolaus increased their target price on Heartflow from $40.00 to $45.00 and gave the stock a "buy" rating in a research note on Friday, August 14th. Finally, Weiss Ratings raised Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Heartflow presently has a consensus rating of "Moderate Buy" and an average price target of $43.43.
View Our Latest Stock Report on HTFL
About Heartflow
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
